Tag: biotech and pharmaceutical companies

December 21, 2016

Bristol-Myers Squibb and Calithera Biosciences Announce Clinical Collaboration to Evaluate Opdivo (nivolumab) in Combination with CB-839 in Clear Cell Renal Cell Carcinoma

Bristol-Myers Squibb Company and Calithera Biosciences today announced a clinical trial collaboration to evaluate Bristol-Myers Squibb’s Opdivo in combination with...
October 9, 2016

5 Top NASDAQ Biotech Stocks: Aurinia Pharmaceuticals Up 90 Percent Year-To-Date

Last week's top gainer was Aurinia Pharmaceuticals, followed by Neptune Tech & Bioresources, Madrigal Pharmaceuticals, Biodel and Curis
May 17, 2016

Cancer Genetics, Inc. Launches The Most Comprehensive & Clinically Actionable Next Generation Sequencing Panel in Precision Medicine, FOCUS::Lymphoma ™

FOCUS::Lymphoma™ panel is being used to power several clinical trials with biotech and pharmaceutical companies, and is now available for...
May 3, 2016

Quintiles to Merge with IMS Health in $9 Billion Deal

It's a merger of equals between Quintiles and IMS Health.
August 12, 2015

Privacy Concerns Clash with Financial Incentives in Connected Healthcare Market

Personal data has the potential to radically transform the healthcare industry. However, consumers remain wary of the potential privacy violations...
December 12, 2013

AbbVie, Puma Biotechnology, Gilead Sciences and Zogenix Reach Significant Milestones this Month

Several biotech and pharmaceutical companies have reached significant catalysts in the first half of December including positive clinical-trial results and,...
December 5, 2013

Not Your Father's Diagnostics: Ram Selvaraju on How Molecular Genomics Invigorate the Sector

An old investment principle says the equity upside of diagnostics and tools companies can't hold a candle to that of...